Vendrell, J. A., Solassol, J., Győrffy, B., Vilquin, P., Jarlier, M., Donini, C. F., . . . Cohen, P. A. (2019). Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer. Front Pharmacol.
Citación estilo ChicagoVendrell, Julie A., et al. "Evaluating ZNF217 MRNA Expression Levels As a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer." Front Pharmacol 2019.
Cita MLAVendrell, Julie A., et al. "Evaluating ZNF217 MRNA Expression Levels As a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer." Front Pharmacol 2019.
Precaución: Estas citas no son 100% exactas.